PTF1A and neoplasm: Moses’s laboratory generated TGF-βRII knock out mice crossed with Ptf1a-Cre; LSL-KrasG12D and showed that compound mice developed well differentiated PDAC [13] mostly highlighting the role as a tumor suppressor.